13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001325083
Total reported value
$179.3M
$179.3M
38 檔
41.8%
During the Q3 2025 filing period, Knoll Capital Management, LLC (CIK: 0001325083) submitted its Form 13F report to the U.S. SEC, disclosing a tracked public equity portfolio valued at $179.3M across 38 reported positions.
In Q3 2025, Knoll Capital Management, LLC displayed an active expansion posture, initiating 6 new positions and adding to 3 existing holdings, outstripping position reductions.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | ALDX | Aldeyra Therapeutics Inc | Stock-Other | 15.32% | +1.36% | — | |
| 2 | BHVN | Biohaven Ltd. | Stock-Other | 7.20% | -10.93% | — | |
| 3 | GLD | Spdr Gold Shares | ETF-Commodities | 6.10% | — | — | |
| 4 | ✓ | Entera Bio LTD | Stock-Other | 6.05% | +2.22% | — | |
| 5 | MGTX | MeiraGTx Holdings plc | Stock-Other | 5.51% | +3.41% | — | |
| 6 | KGC | Kinross Gold CORP | Stock-Materials | 5.46% | -1.20% | -6.82% | |
| 7 | ✓ | Avadel Pharmaceuticals PLC ADR | Stock-Other | 4.91% | — | — | |
| 8 | AEM | Agnico Eagle Mines LTD | Stock-Materials | 4.76% | -1.38% | -4.96% | |
| 9 | AYS1 | Sandstorm Gold LTD | Stock-Other | 4.70% | — | — | |
| 10 | SEA1EUR | Seabridge Gold Inc | Stock-Other | 4.10% | -0.44% | — | |
| 11 | OCUL | Ocular Therapeutix Inc | Stock-Other | 3.76% | +3.48% | — | |
| 12 | ELTX | Elicio Therapeutics Inc | Stock-Other | 3.70% | -1.10% | — | |
| 13 | FNV | Franco-nevada CORP | Stock-Materials | 2.99% | -0.67% | — | |
| 14 | NUVB | Nuvation Bio Inc | Stock-Other | 2.97% | +1.49% | — | |
| 15 | CGAU | Centerra Gold Inc | Stock-Other | 2.86% | -0.36% | -59.49% | |
| 16 | APLT | Applied Therapeutics Inc | Stock-Other | 2.52% | — | — | |
| 17 | ALT | Altimmune Inc | Stock-Other | 2.27% | — | — | |
| 18 | PAAS | Pan American Silver CORP | Stock-Materials | 2.08% | -0.53% | — | |
| 19 | SLV | Ishares Silver Trust | ETF-Commodities | 1.82% | — | — | |
| 20 | RGLD | Royal Gold Inc | Stock-Materials | 0.97% | -1.58% | — | |
| 21 | CDE | Coeur Mining Inc | Stock-Materials | 0.97% | -0.12% | — | |
| 22 | AGI | Alamos Gold Inc-class A | Stock-Materials | 0.93% | -0.38% | — | |
| 23 | TFPM | Triple Flag Precious Met | Stock-Materials | 0.92% | -0.30% | — | |
| 24 | V | Visa Inc-class A Shares | Stock-Financials | 0.89% | — | — | |
| 25 | PM | Philip Morris International | Stock-Consumer Staples | 0.87% | +0.09% | — | |
| 26 | ITA | Ishares U.s. Aerospace & Def | ETF-Other | 0.86% | +0.10% | — | |
| 27 | WPM | Wheaton Precious Metals CORP | Stock-Materials | 0.75% | -0.13% | — | |
| 28 | NOC | Northrop Grumman CORP | Stock-Industrials | 0.71% | -0.20% | — | |
| 29 | NEWP | New Pacific Metals CORP | Stock-Other | 0.70% | -0.02% | — | |
| 30 | BAH | Booz Allen Hamilton Holdings | Stock-Industrials | 0.70% | +2.62% | — | |
| 31 | DEO | Diageo Plc-sponsored Adr | Stock-Consumer Staples | 0.35% | — | — | |
| 32 | DC | Dakota Gold CORP | Stock-Other | 0.30% | -0.05% | — | |
| 33 | MREO | Mereo Biopharma Group Pl-adr | Stock-Other | 0.29% | — | — | |
| 34 | ✓ | Hookipa Pharma | Stock-Other | 0.25% | — | — | |
| 35 | OBIO | Orchestra Biomed Holdings In | Stock-Other | 0.23% | — | — | |
| 36 | ABEO | Abeona Therapeutics Inc | Stock-Other | 0.18% | +0.46% | — | |
| 37 | CRDL | Cardiol Therapeutics Inc-a | Stock-Other | 0.06% | -0.07% | EXIT | |
| 38 | ✓ | Orgenesis, Inc. | Stock-Other | 0.03% | -0.01% | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | KGC | Kinross Gold CORP | +1.9% | -6.82% | Trim |
| 2 | ✓ | Avadel Pharmaceuticals PLC ADR | +1.9% | — | Unchanged |
| 3 | NUVB | Nuvation Bio Inc | +1.8% | — | Unchanged |
| 4 | SEA1EUR | Seabridge Gold Inc | +1.7% | — | Unchanged |
| 5 | AYS1 | Sandstorm Gold LTD | +1.3% | — | Unchanged |
| 6 | ELTX | Elicio Therapeutics Inc | +1.2% | — | Unchanged |
| 7 | OCUL | Ocular Therapeutix Inc | +0.9% | — | Unchanged |
| 8 | AEM | Agnico Eagle Mines LTD | +0.9% | -4.96% | Trim |
| 9 | CDE | Coeur Mining Inc | +0.6% | — | Unchanged |
| 10 | FNV | Franco-nevada CORP | +0.4% | — | Unchanged |
| 11 | NEWP | New Pacific Metals CORP | +0.4% | — | Unchanged |
| 12 | AGI | Alamos Gold Inc-class A | +0.2% | — | Add |
| 13 | SLV | Ishares Silver Trust | +0.2% | — | Unchanged |
| 14 | RGLD | Royal Gold Inc | +0.2% | — | Add |
| 15 | WPM | Wheaton Precious Metals CORP | +0.1% | — | Unchanged |
| 16 | GLD | Spdr Gold Shares | +0.1% | — | Unchanged |
| 17 | ITA | Ishares U.s. Aerospace & Def | +0.1% | — | Unchanged |
| 18 | APLT | Applied Therapeutics Inc | 0% | — | Unchanged |
| 19 | MGTX | MeiraGTx Holdings plc | — | — | Unchanged |
| 20 | CRDL | Cardiol Therapeutics Inc-a | — | — | Unchanged |
| 21 | NOC | Northrop Grumman CORP | 0% | — | Unchanged |
| 22 | ✓ | Orgenesis, Inc. | -0.1% | — | Unchanged |
| 23 | MREO | Mereo Biopharma Group Pl-adr | -0.1% | — | Unchanged |
| 24 | ✓ | Hookipa Pharma | -0.1% | — | Unchanged |
| 25 | DEO | Diageo Plc-sponsored Adr | -0.1% | — | Unchanged |
| 26 | PM | Philip Morris International | -0.2% | — | Unchanged |
| 27 | BAH | Booz Allen Hamilton Holdings | -0.2% | — | Unchanged |
| 28 | V | Visa Inc-class A Shares | -0.2% | — | Unchanged |
| 29 | ✓ | Entera Bio LTD | -0.5% | — | Unchanged |
| 30 | ALT | Altimmune Inc | -1.4% | — | Unchanged |
| 31 | ALDX | Aldeyra Therapeutics Inc | -5.2% | — | Unchanged |
| 32 | BHVN | Biohaven Ltd. | -5.8% | — | Add |
| 33 | CGAU | Centerra Gold Inc | — | NEW | New buy |
| 34 | PAAS | Pan American Silver CORP | — | NEW | New buy |
| 35 | EQX | Equinox Gold CORP | — | EXIT | Sold out |
| 36 | SKE | Skeena Resources LTD | — | EXIT | Sold out |
| 37 | MQ8 | Mag Silver CORP | — | EXIT | Sold out |
| 38 | TFPM | Triple Flag Precious Met | — | NEW | New buy |
| 39 | DC | Dakota Gold CORP | — | NEW | New buy |
| 40 | VRNA | Verona Pharma PLC - Adr | — | EXIT | Sold out |
| 41 | OBIO | Orchestra Biomed Holdings In | — | NEW | New buy |
| 42 | ABEO | Abeona Therapeutics Inc | — | NEW | New buy |
According to official SEC Form 13F filings, Knoll Capital Management, LLC reported a total U.S. public equity portfolio value of $179.3M across 38 disclosed positions in Q3 2025.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including ALDX, BHVN, GLD) accounted for 41.8% of total reported equity market value during Q3 2025.
Top New Position Initiated
CGAU
市值: $5.3M
Top Position Liquidated / Trimmed
EQX
前期市值: $3.8M
During Q3 2025, Knoll Capital Management, LLC's top holdings by market value included ALDX (15.3%)、BHVN (7.2%)、GLD (6.1%). The largest single position, ALDX, represented 15.3% of total portfolio value.
In Q3 2025, Knoll Capital Management, LLC made 15 total portfolio adjustments, initiating 6 new buys, adding to 3 positions, trimming 2 holdings, and fully liquidating 4 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.